SPRINGFIELD, Mo. (June 19, 2013) When an improvised explosive device blows up in the face of an American soldier, medics must rush to treat the life-threatening injuries. That often means injuries to the eyes, which account for nearly 40 percent of all war wounds, can go untreated for days, frequently resulting in blindness.
Now, scientists at Mercy Research and Development (R&D) in Springfield have a solution, thanks to a $4.8 million grant from the Department of Defense.
Senator Roy Blunt will join members of the Mercy R&D team to unveil the new technology that will make it possible for medics to treat immediately eye wounds on the battlefield. Please join us for this exciting announcement, which will also detail how this same patented technology can be used to benefit everyday Americans.